Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T08:53:40.906Z Has data issue: false hasContentIssue false
  • English
  • Français

Long-term medication in depot clinics and patients' rights: an issue for assertive outreach

Published online by Cambridge University Press:  02 January 2018

Nigel Eastwood  and
Robert Pugh
Nigel Eastwood
Affiliation:
Norfolk Mental Health Care, NHS Trust, Hellesdon Hospital, Drayton High Road, Norwich NR6 5BE
Robert Pugh*
Affiliation:
Norfolk Mental Health Care, NHS Trust, Hellesdon Hospital, Drayton High Road, Norwich NR6 5BE
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

This study investigated the knowledge and attitude of 100 patients about their depot neuroleptic medication. Patients were well informed about their medication, particularly those seen in depot clinics. Most patients were content with service delivery but 48% did not realise that they had a choice about receiving their treatment. This aspect of patients' rights should be addressed and demands sensitive management in the case of depot refusers, or when assertive outreach is planned. We suggest that such issues should be incorporated into an educational programme and discussed with patients when they are relatively well.

Type
Original Papers
Information
Psychiatric Bulletin , Volume 21 , Issue 5 , May 1997 , pp. 273 - 275
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Brabbins, C., Butler, J. & Bentall, R. (1996) Consent to neuroleptic medication for schizophrenia: clinical, ethical and legal issues. British Journal of Psychiatry, 168, 540–544.CrossRefGoogle ScholarPubMed
Burns, B. J. & Santos, A. B. (1995) Assertive community treatment: an update of randomised trials. Psychiatric Services, 46, 669–675.Google Scholar
Department of Health and the Welsh Office (1993) Mental Health Act 1983 Code of Practice. London: HMSO.Google Scholar
Department of Health (1996) Mental Health Services; The Patients' Charter (Consultation Edition). London: HMSO.Google Scholar
Gilbert, P. L., Harris, M. J., McAdams, L. A., et al (1995) Neuroleptic withdrawal in schizophrenic patients; a review of the literature. Archives of General Psychiatry, 52, 173–188.CrossRefGoogle ScholarPubMed
Hale, A. S. & Wood, C. (1996) Comparison of direct treatment costs for schizophrenia using oral or depot neuroleptics: a pharmacoeconomic analysis. British Journal of Medical Economics, 10, 37–45.Google Scholar
Macpherson, R., Jerrom, B. & Hughes, A. (1996) A controlled study of education about drug treatment in schizophrenia. British Journal of Psychiatry, 168, 709–717.Google Scholar
Singh, V., Hughes, G. & Goh, S. E. (1995) Depot clinic: consumers' viewpoint. Psychiatric Bulletin, 19, 728–730.Google Scholar
Stein, L. I. & Test, M. A. (1980) Alternative to mental hospital treatment: I. Conceptual model, treatment programme, and clinical evaluation. Archives of General Psychiatry, 37, 392–397.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.